CIK 0001800315 · Non-accelerated filer<br>Smaller reporting company
Damora Therapeutics, Inc.
Sign in to watch- Ticker
- DMRA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 371957007
- Phone
- (781) 281-9020
- Business address
- 100 FIFTH AVENUE, SUITE 700, WALTHAM, MA, 02451
- Former names
- Galecto, Inc., Galecto Inc.
- Open-market buys, last 90 days
- $252,875
- in 1 filing
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$252,875. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-09-25 | Munshi Amit Director | Grant or award · Series D Preferred Stock | +1,844 | $27.11 | $50K | 1,844 |
| 2020-09-25 | Khuong Chau Quang Director | Grant or award · Series D Preferred Stock | −148,395 | $27.11 | $4.0M | 148,395 |
| 2020-09-25 | Khuong Chau Quang Director | Grant or award · Series D Preferred Stock | −59,350 | $27.11 | $1.6M | 59,350 |
| 2020-09-25 | Khuong Chau Quang Director | Grant or award · Series D Preferred Stock | −73,773 | $27.11 | $2.0M | 73,773 |
| 2020-06-24 | Pedersen Anders Chief Operating Officer | Grant or award · Stock Option (right to buy) | +142,983 | 142,983 | ||
| 2020-06-24 | Munshi Amit Director | Grant or award · Stock Option (right to buy) | +109,187 | 109,187 | ||
| 2020-06-24 | Schambye Hans T. Chief Executive Officer | Grant or award · Stock Option (right to buy) | +207,976 | 207,976 |
Page 12 of 12 · 227 trades